
Nandrolone-Induced Tumor Progression in Hormone-Sensitive Prostate Cancer: Erratum
Publication year - 2022
Publication title -
clinical nuclear medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000004210
Subject(s) - medicine , nandrolone , prostate cancer , oncology , cancer , prostate , hormone , cancer research , gynecology , anabolism